Autumn Research Update Meeting 2025
Our 2025 Autumn Research Update Meeting will take place once again at the renowned Royal Society of Medicine (RSM), Wimpole Street, London, on Monday 10 November, where guests can look forward to an engaging agenda featuring the latest updates from our funded research. Theme: Revolutionising...
Learn more
The PD-STAT/Simvastatin study results
Why is this important? In 2012, an international committee of Parkinson’s experts brought together by Cure Parkinson’s prioritised simvastatin for clinical evaluation in Parkinson’s. The International Linked Clinical Trials (iLCT) committee believed that there was considerable supporting evidence indicating that this widely used medication may…
Dexamethasone for COVID – and perhaps Parkinson’s?
Recent studies screening medical record databases suggest anti-inflammatory drugs like dexamethasone may reduce the risk of developing Parkinson’s.
Webinar – Prodromal Parkinson’s
Presented by the Journal of Parkinson’s Disease, Cure Parkinson’s and Van Andel Institute. Prodromal Parkinson’s is the stage at which individuals exhibit signs and symptoms that indicate a higher than average risk of developing motor symptoms and a diagnosis of Parkinson’s in the future. The…
A biomarker for Parkinson’s?
A research report published this week, highlights a protein that could represent the first ‘biomarker’ for Parkinson’s progression.
The epigenetics of Parkinson’s.
Researchers at the Van Andel Institute in Grand Rapids (Michigan) have identified a “master regulator” gene switch that may protect the brain from neurodegenerative processes associated with Parkinson’s.